Literature DB >> 16137875

Evaluation of smoking cessation success in adults.

C Raherison1, A Marjary, B Valpromy, S Prevot, H Fossoux, A Taytard.   

Abstract

BACKGROUND: Smoking is a preventable cause of increased morbidity and mortality. Therefore, interventions have been used to assist smokers in overcoming their addiction. The aim of the study was to describe factors associated with smoking cessation, in patients applied to our smoking cessation (SC) unit in 1999, in a prospective study.
METHODS: Patients were followed-up during two years. Detailed medical history, Fagerstrom test, Hospital Anxiety and Depression (HAD) scale questionnaire, Motivation scale and replacement therapy were systematically recorded.
RESULTS: Three hundred patients (58% men, 42% women) applied to the SC unit from January to December 1999. The mean age was 42 yrs old. They smoked in average 24 cig/d. Mean duration of smoking was 20 years. Fagerstrom score was 5.86 (min 0; max: 10). Patients seemed to be more anxious (score 9.6) than depressed (5.09), according to the HAD score. 79% of them received both psychosocial intervention, pharmacotherapy and nicotine replacement therapy. 66% of patients were followed-up (n=198). Two years later, the smoking cessation rate was 12% (n=36). Motivation, Fagerstrom and HAD scores were not associated with the quitting rate. Quitting rate was higher (25.9%) in patients who attempted to quit smoking for the first time than in others (19%). By contrast, the quitting rate was significantly associated with age (P=0.03).
CONCLUSION: Success to quit smoking was positively associated with age, and negatively with alcohol dependence.

Entities:  

Mesh:

Year:  2005        PMID: 16137875     DOI: 10.1016/j.rmed.2004.12.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  Efficacy of team-based financial incentives for smoking cessation in the workplace.

Authors:  Chang Dong Yeo; Hea Yeon Lee; Jick Hwan Ha; Hyeon Hui Kang; Ji Young Kang; Sung Kyoung Kim; Myung Sook Kim; Hwa Sik Moon; Sang Haak Lee
Journal:  Yonsei Med J       Date:  2015-01       Impact factor: 2.759

2.  A 5-Factor Framework for Assessing Tobacco Use Disorder.

Authors:  Matthew Bucklin
Journal:  Tob Use Insights       Date:  2021-02-26

3.  Smoking status impacts treatment efficacy in smoke-induced lung inflammation: A pre-clinical study.

Authors:  Nadia Milad; Marie Pineault; Félix Tremblay; Joanie Routhier; Ariane Lechasseur; Marie-Josée Beaulieu; Sophie Aubin; Mathieu C Morissette
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

4.  Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches.

Authors:  Seung Kwon Myung; Hong Gwan Seo; Sohee Park; Yeol Kim; Dong Jin Kim; Do Hoon Lee; Moon Woo Seong; Myung Hyun Nam; Seung Won Oh; Ji Ae Kim; Mi Young Kim
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

5.  Relationship between education levels and booster counselling sessions on smoking cessation among Chinese smokers.

Authors:  Lei Wu; Yao He; Bin Jiang; Fang Zuo; Qinghui Liu; Li Zhang; Changxi Zhou; Miao Liu; Hongyan Chen
Journal:  BMJ Open       Date:  2015-08-05       Impact factor: 2.692

6.  Factors associated with continued smoking after the diagnosis of type 2 diabetes: a retrospective study in the Korean cohort.

Authors:  Mi Hee Cho; Sung Min Kim; Kiheon Lee; Sang Min Park; Jooyoung Chang; Seulggie Choi; Kyuwoong Kim; Hye-Yeon Koo; Ji-Hye Jun
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.